Abstract
Case description We present a case of a seventy-eight year-old man who developed vocal cord paralysis without any sign of peripheral neuropathy during the treatment of Mantle Cell Lymphoma. He first presented in 2008 with a few bilateral small inguinal lymph nodes. Inguinal lymph node biopsy demonstrated Mantle Cell Lymphoma. Flow cytometry studies of peripheral blood and bone marrow cells were compatible with Mantle Cell Lymphoma. R-CHOP chemotherapy triweekly (Rituximab; Cyclophosphamide; Adriamycin; Vincristine; and Methylprednisolone) was planned. At the end of the second cycle, the patient complained of hoarseness without any symptoms of dysphagia or odynophagia. Direct flexible laryngoscopy showed bilateral vocal cord paralysis. Vincristine was discontinued and the patient’s voice gradually resolved in about 4 months. Conclusion Vincristine may cause peripheral, autonomic and cranial neuropathies. However cranial nerve involvement is quite uncommon.
References
Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve. 1987;10:80–4.
Green LS, Donoso JA, Heller-Bettinger IE, Samson FE. Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol. 1977;1(3):255–62.
Oakes SG, Santone KS, Powis G. Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. J Natl Cancer Inst. 1987;79:155–61.
Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003;25(4):316–20.
Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man: clinical, electrophysiological, and pathological studies. J Neurol Sci. 1970;10(2):107–31.
Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine induced neuropathy. Muscle Nerve. 1987;10(1):80–4.
Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994;20(2):191–214.
Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemia. Cancer Res. 1963;23:613–21.
Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr. 2006;73:531–3.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Kuruvilla G, Perry S, Wilson B, El-Hakim H. The natural history of vincristine-induced laryngeal paralysis in children. Arch Otolaryngol Head Neck Surg. 2009;135(1):101–5.
Naithani R, Dolai TK, Kumar R. Bilateral vocal cord paralysis following treatment with vincristine. Indian Pediatr. 2009;46(1):68–9.
Latiff ZA, Kamal NA, Jahendran J, Alias H, Goh BS, Syed Zakaria SZ, et al. Vincristine-induced vocal cord palsy: case report and review of the literature. J Pediatr Hematol Oncol. 2010;32(5):407–10.
Farruggia P, Tropia S, Cannella S, Bruno G, Oddo G, D’Angelo P. Vocal cord palsy after vincristine treatment in a child and the inefficacy of glutamic acid in the prevention of relapse: a case report. J Med Case Rep. 2012;6(1):128.
Whittaker JA, Griffith IP. Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. Br Med J. 1977;1:1251–2.
Rezvani K, Bain BJ, Coulter CA. Loss of singing ability caused by vincristine. Clin Lab Haematol. 1998;20(1):47–8.
Anghelescu DL, De Armendi AJ, Thompson JW, Sillos EM, Pui CH, Sandlund JT. Vincristine induced vocal cord paralysis in an infant. Paediatr Anaesth. 2002;12:168–70.
Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137–42.
Conflicts of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yalin, S.F., Trabulus, S., Yalin, A.S. et al. Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine. Int J Clin Pharm 35, 306–308 (2013). https://doi.org/10.1007/s11096-013-9751-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-013-9751-6